These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30224376)

  • 21. Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line.
    Wang X; Liu Y; Zhou K; Zhang G; Wang F; Ren J
    Int J Clin Exp Pathol; 2015; 8(5):5105-12. PubMed ID: 26191205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties.
    Rose AA; Annis MG; Dong Z; Pepin F; Hallett M; Park M; Siegel PM
    PLoS One; 2010 Aug; 5(8):e12093. PubMed ID: 20711474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.
    Tiran V; Stanzer S; Heitzer E; Meilinger M; Rossmann C; Lax S; Tsybrovskyy O; Dandachi N; Balic M
    PLoS One; 2017; 12(4):e0175223. PubMed ID: 28423035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer.
    Choi AR; Park JR; Kim RJ; Kim SR; Cho SD; Jung JY; Nam JS
    Biochem Biophys Res Commun; 2012 Aug; 425(2):436-42. PubMed ID: 22846569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33.
    Liguori M; Digifico E; Vacchini A; Avigni R; Colombo FS; Borroni EM; Farina FM; Milanesi S; Castagna A; Mannarino L; Craparotta I; Marchini S; Erba E; Panini N; Tamborini M; Rimoldi V; Allavena P; Belgiovine C
    Cell Mol Immunol; 2021 Mar; 18(3):711-722. PubMed ID: 32728200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PM2.5 induces EMT and promotes CSC properties by activating Notch pathway in vivo and vitro.
    Wang Y; Zhong Y; Hou T; Liao J; Zhang C; Sun C; Wang G
    Ecotoxicol Environ Saf; 2019 Aug; 178():159-167. PubMed ID: 31002970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The laminin-derived peptide C16 regulates GPNMB expression and function in breast cancer.
    Smuczek B; Santos ES; Siqueira AS; Pinheiro JJV; Freitas VM; Jaeger RG
    Exp Cell Res; 2017 Sep; 358(2):323-334. PubMed ID: 28689015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells.
    Fomeshi MR; Ebrahimi M; Mowla SJ; Khosravani P; Firouzi J; Khayatzadeh H
    Cell Mol Biol Lett; 2015 Sep; 20(3):448-65. PubMed ID: 26208390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
    Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
    Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGF-β1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes.
    Liu F; Kong X; Lv L; Gao J
    Cancer Lett; 2015 Apr; 359(2):288-98. PubMed ID: 25633840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer stem cell generation during epithelial-mesenchymal transition is temporally gated by intrinsic circadian clocks.
    De A; Beligala DH; Sharma VP; Burgos CA; Lee AM; Geusz ME
    Clin Exp Metastasis; 2020 Oct; 37(5):617-635. PubMed ID: 32816185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cells: their role in breast cancer development and resistance to treatment.
    Nicolini A; Ferrari P; Fini M; Borsari V; Fallahi P; Antonelli A; Berti P; Carpi A; Miccoli P
    Curr Pharm Biotechnol; 2011 Feb; 12(2):196-205. PubMed ID: 21044007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
    Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
    Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer.
    Yardley DA; Weaver R; Melisko ME; Saleh MN; Arena FP; Forero A; Cigler T; Stopeck A; Citrin D; Oliff I; Bechhold R; Loutfi R; Garcia AA; Cruickshank S; Crowley E; Green J; Hawthorne T; Yellin MJ; Davis TA; Vahdat LT
    J Clin Oncol; 2015 May; 33(14):1609-19. PubMed ID: 25847941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells.
    Ota I; Masui T; Kurihara M; Yook JI; Mikami S; Kimura T; Shimada K; Konishi N; Yane K; Yamanaka T; Kitahara T
    Oncol Rep; 2016 Jan; 35(1):261-6. PubMed ID: 26498709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.
    Park JR; Kim RJ; Lee YK; Kim SR; Roh KJ; Oh SH; Kong G; Kang KS; Nam JS
    J Hepatol; 2011 Jan; 54(1):122-31. PubMed ID: 20952084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures.
    Xie G; Yao Q; Liu Y; Du S; Liu A; Guo Z; Sun A; Ruan J; Chen L; Ye C; Yuan Y
    Int J Oncol; 2012 Apr; 40(4):1171-9. PubMed ID: 22134360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.